These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2837625)

  • 41. Pharmacokinetics of a low molecular weight heparin [Fragmin] in young and elderly subjects.
    Simoneau G; Bergmann JF; Kher A; Soria C; Tobelem G
    Thromb Res; 1992 Jun; 66(5):603-7. PubMed ID: 1326135
    [No Abstract]   [Full Text] [Related]  

  • 42. [Not Available].
    Steurer J
    Praxis (Bern 1994); 2018 Nov; 107(24):1357-1358. PubMed ID: 30482114
    [No Abstract]   [Full Text] [Related]  

  • 43. [Thromboembolism and dietetics; comments with respect to the panoramic change of internal diseases].
    BERG HH
    Dtsch Med Wochenschr; 1954 May; 79(20):801-3. PubMed ID: 13161607
    [No Abstract]   [Full Text] [Related]  

  • 44. Double-blind trials and alternative medicine.
    Hodson AH
    J R Soc Med; 1993 Mar; 86(3):182. PubMed ID: 20894862
    [No Abstract]   [Full Text] [Related]  

  • 45. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Rutjes AW; Porreca E; Candeloro M; Valeriani E; Di Nisio M
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD008500. PubMed ID: 33337539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
    Di Nisio M; Porreca E; Candeloro M; De Tursi M; Russi I; Rutjes AW
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD008500. PubMed ID: 27906452
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction).
    Alikhan R; Bedenis R; Cohen AT
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD003747. PubMed ID: 24804622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders.
    Dunn CJ; Sorkin EM
    Drugs; 1996 Aug; 52(2):276-305. PubMed ID: 8841743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins.
    Verstraete M
    Drugs; 1990 Oct; 40(4):498-530. PubMed ID: 1964634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prevention of thromboembolism in hysterectomies with low molecular weight heparin Fragmin].
    Briel RC; Doller P; Hermann CP
    Geburtshilfe Frauenheilkd; 1988 Mar; 48(3):160-4. PubMed ID: 2836259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Peroperative thromboembolism prophylaxis: low-dose heparin or low molecular weight heparin-DHE, the advantages and disadvantages. A prospective randomized study].
    Hoffmann R; Largiadèr F; Roethlin M
    Helv Chir Acta; 1987 Dec; 54(4):521-5. PubMed ID: 2833477
    [No Abstract]   [Full Text] [Related]  

  • 52. [Prevention of thromboembolic complications in orthopedic surgery].
    Kher A; Heilmann JJ; Barbier P
    Therapie; 1988 May; 43(3):193-8. PubMed ID: 2844005
    [No Abstract]   [Full Text] [Related]  

  • 53. A randomized double-blind study between a low molecular weight heparin Kabi 2165 and standard heparin in the prevention of deep vein thrombosis in general surgery. A French multicenter trial.
    Caen JP
    Thromb Haemost; 1988 Apr; 59(2):216-20. PubMed ID: 2838923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effectiveness of low molecular weight heparin (Fragmin) in the prevention of thromboembolism in internal medicine patients. A randomized double-blind study].
    Poniewierski M; Barthels M; Kuhn M; Poliwoda H
    Med Klin (Munich); 1988 Mar; 83(7):241-5, 278. PubMed ID: 2837625
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.